+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novavax Inc - logo

Novavax is a clinical-stage vaccine company that develops recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization, seasonal quadrivalent influenza and pandemic H7N9 vaccines, a vaccine candidate against Ebola Virus and others. Founded in 1987, it is headquartered in Gaithersburg, Maryland.

Collaboration Deals in Pharmaceuticals 2020-2025 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2020-2025

  • Report
  • September 2025
  • 950 Pages
  • Global
From
From
Preventive Medicines Market - Global Forecast 2025-2032 - Product Thumbnail Image

Preventive Medicines Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 188 Pages
  • Global
From
Distribution Deals in Pharmaceuticals and Biotechnology 2020-2025 - Product Thumbnail Image

Distribution Deals in Pharmaceuticals and Biotechnology 2020-2025

  • Report
  • September 2025
  • 300 Pages
  • Global
From
From
Antimicrobial Therapeutics Market 2024-2028 - Product Thumbnail Image

Antimicrobial Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 175 Pages
  • Global
From
From
From
From
Liposomal Drug Delivery Devices Market Report 2025 - Product Thumbnail Image

Liposomal Drug Delivery Devices Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
COVID-19 Clinical Trials Market - Global Forecast 2025-2032 - Product Thumbnail Image

COVID-19 Clinical Trials Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 190 Pages
  • Global
From
From
From
From
Loading Indicator